These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 6655636)
1. Preoperative cervical dilatation with a single long-acting prostaglandin analog suppository. An alternative to traumatic mechanical dilatation before surgical evacuation. Kent DR; Goldstein AI; Milokovich D J Reprod Med; 1983 Nov; 28(11):778-80. PubMed ID: 6655636 [TBL] [Abstract][Full Text] [Related]
2. The role of a long-acting vaginal suppository of 15-ME-PGF2 alpha in first and second trimester abortion. Lauersen NH; Wilson KH Adv Prostaglandin Thromboxane Res; 1980; 8():1435-41. PubMed ID: 7376994 [No Abstract] [Full Text] [Related]
3. [Development of a long-acting vaginal suppository for termination of 2d trimester pregnancy and for preoperative cervical dilatation]. Bygdeman M; Gréen K; Lundström V Lakartidningen; 1977 Nov; 74(46):4107-9. PubMed ID: 926943 [No Abstract] [Full Text] [Related]
4. Evaluation of intramuscular 15 (S) 15 methyl prostaglandin F2 alpha for menstrual regulation and preoperative cervical dilatation. Jain S; Bharti P; Chauhan M; Kalia S; Vohra S Indian J Med Res; 1983 Jan; 77():49-53. PubMed ID: 6862559 [No Abstract] [Full Text] [Related]
5. Preabortion cervical dilatation with a low-dose prostaglandin suppository. A comparison of two analogs. Lauersen NH; Graves ZR J Reprod Med; 1984 Feb; 29(2):133-5. PubMed ID: 6708030 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of low-dose 15-methyl prostaglandin F2 alpha for cervical ripening in the first trimester of pregnancy. Arias F Am J Obstet Gynecol; 1984 May; 149(1):100-1. PubMed ID: 6720761 [No Abstract] [Full Text] [Related]
7. Vaginal administration of 15-methyl-PGF2 alpha methyl ester for preoperative cervical dilatation. Task force on prostaglandins for fertility regulation. The World Health Organization. Contraception; 1981 Mar; 23(3):251-9. PubMed ID: 7016432 [TBL] [Abstract][Full Text] [Related]
8. Cervical dilatation in late first trimester termination by prostaglandin, hylase and isogel. Mandlekar AV; Ganguli AC; Krishna UR; Purandare VN Prostaglandins Med; 1981 Apr; 6(4):381-7. PubMed ID: 7025067 [TBL] [Abstract][Full Text] [Related]
9. Cervical dilation with prostaglandin F2 alpha for first trimester abortion. Natrajan PK; Tzingounis VA South Med J; 1986 Jul; 79(7):830-1. PubMed ID: 3460179 [TBL] [Abstract][Full Text] [Related]
10. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester. Scher J; Jeng DY; Kerenyi TD Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575 [TBL] [Abstract][Full Text] [Related]
11. Cervical priming prior to first-trimester suction abortion with a single 15-methyl-prostaglandin F2 alpha vaginal suppository. Lauersen NH; Seidman S; Wilson KH Am J Obstet Gynecol; 1979 Dec; 135(8):1116-8. PubMed ID: 391045 [No Abstract] [Full Text] [Related]
12. Comparison of two prostaglandins used to terminate midtrimester pregnancy. Gookin KS; White CK; Whitworth NS; Wiser WL; Morrison JC South Med J; 1984 Jun; 77(6):717-8, 721. PubMed ID: 6587588 [TBL] [Abstract][Full Text] [Related]
13. [A clinical study on the interruption of first and second trimester pregnancies by vaginal suppositories of dl-15 methyl PGF2 alpha methyl ester]. Fan GS; Xu YD; Wu YM; Hu CH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):65-8. PubMed ID: 2954692 [No Abstract] [Full Text] [Related]
14. [Preoperative dilatation of the cervix uteri by vaginal application of 9-deoxo-16, 16-dimethyl-9-methylene PGE2 in pregnancy interruption during the 1st trimester. Double-blind clinical study]. Friedli A; De Grandi P J Gynecol Obstet Biol Reprod (Paris); 1986; 15(2):215-21. PubMed ID: 3522723 [TBL] [Abstract][Full Text] [Related]
15. [Effect of 15-methyl-prostaglandin F2 alpha used for dilating the cervix uteri before abortion on endogenous prostaglandin F2 alpha synthesis]. Goncharova VN; Morozova MS; Razina LG; Manuilova IA; Murashko LE Akush Ginekol (Mosk); 1981 Dec; (12):37-8. PubMed ID: 6950671 [TBL] [Abstract][Full Text] [Related]
16. Preoperative dilatation of the cervix by single vaginal administration of 15-methyl-PGF2alpha-methyl ester. Ganguli AC; Gréen K; Bygdeman M Prostaglandins; 1977 Oct; 14(4):779-84. PubMed ID: 339282 [TBL] [Abstract][Full Text] [Related]
17. The cervix-ripening effect of 15-methyl-prostaglandin F2 alpha methyl ester before vacuum aspiration for termination of early pregnancy in primigravidae. Wang YF; Jin YC; Wu YE; Gu LJ; Xie XH Chin Med J (Engl); 1989 Mar; 102(3):200-2. PubMed ID: 2503307 [TBL] [Abstract][Full Text] [Related]
18. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories. Marrs RP; Brenner PF; Roy S; Mishell DR Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157 [TBL] [Abstract][Full Text] [Related]
19. Effects of prostaglandin E2 analogue suppository on blood loss in suction abortion. Sidhu MS; Kent DR Obstet Gynecol; 1984 Jul; 64(1):128-30. PubMed ID: 6738937 [TBL] [Abstract][Full Text] [Related]
20. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester. Roy S; Brenner PF; Marrs RP; Mishell DR Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]